Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
Primary Care
What is your approach to a patient with rheumatoid arthritis and moderate disease activity on 25 mg of PO methotrexate?
Do you switch to SQ MTX, or is it best to add tx, such as a TNFi?
Answer from: at Community Practice
Switching to sub cu may work for low disease activity, but not moderate.
Sign in or Register to read more
10978
Related Questions
How do you approach treatment intensification in patients with RA and low disease activity but not in remission, considering the potential risks of increased immunosuppression?
How do you counsel patients with RA stable on csDMARDs on whether to attempt tapering or not?
Would you uptitrate methotrexate dosing when a patient flares on a TNFi and methotrexate 15 mg weekly?
What is your approach to monitoring patients referred for high titer +RF and +CCP but without active symptoms of inflammatory arthritis?
How do you manage oral ulcers as a side effect from leflunomide?
Do you generally find plain radiographs useful as part of your baseline evaluation in suspected rheumatoid arthritis?
How would you manage a patient with hidradenitis suppurativa and inflammatory arthritis (RA vs. PsA)?
Are you comfortable trying a different JAK inhibitor in patients with prior JAK inhibitor allergy?
Are there any recommendations for restarting JAKi after a provoked DVT?
What is your approach for cancer screening for elderly onset RA?